|
IL297391A
(en)
|
2020-04-20 |
2022-12-01 |
Tenaya Therapeutics Inc |
An adeno-associated virus with an engineered capsid
|
|
WO2022173847A2
(en)
*
|
2021-02-09 |
2022-08-18 |
Affinia Therapeutics Inc. |
Recombinant aavs with improved tropism and specificity
|
|
CA3216419A1
(en)
*
|
2021-04-23 |
2022-10-27 |
Greg NACHTRAB |
Tissue-targeted modified aav capsids and methods of use thereof
|
|
US20250090688A1
(en)
*
|
2021-08-05 |
2025-03-20 |
The Broad Institute, Inc. |
Engineered muscle targeting compositions
|
|
CN118202060A
(zh)
|
2021-10-05 |
2024-06-14 |
再生生物股份有限公司 |
用于重组aav生产的组合物和方法
|
|
WO2023060113A1
(en)
|
2021-10-05 |
2023-04-13 |
Regenxbio Inc. |
Compositions and methods for recombinant aav production
|
|
MX2024004217A
(es)
|
2021-10-08 |
2024-06-26 |
Dyno Therapeutics Inc |
Variantes de cápside y métodos de uso de estas.
|
|
US20250249052A1
(en)
*
|
2022-04-07 |
2025-08-07 |
Kate Therapeutics, Inc. |
Compositions and methods for muscle disorders
|
|
WO2023198828A1
(en)
*
|
2022-04-13 |
2023-10-19 |
Universitat Autònoma De Barcelona |
Treatment of neuromuscular diseases via gene therapy that expresses klotho protein
|
|
EP4707399A2
(en)
*
|
2022-06-10 |
2026-03-11 |
Généthon |
Peptide-modified aav capsid with enhanced muscle transduction efficiency
|
|
KR20250135916A
(ko)
*
|
2022-12-17 |
2025-09-15 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
심장 및 골격근 특이적 표적화 모티프를 갖는 재조합 aav 돌연변이체 벡터 및 이를 포함하는 조성물
|
|
TW202502803A
(zh)
|
2023-03-10 |
2025-01-16 |
美商戴諾治療公司 |
衣殼多肽及其使用方法
|
|
EP4680741A2
(en)
|
2023-03-15 |
2026-01-21 |
RegenxBio Inc. |
Exon skipping gene therapy constructs, vectors and uses thereof
|
|
TW202525832A
(zh)
|
2023-08-31 |
2025-07-01 |
美商戴諾治療公司 |
衣殼多肽及其使用方法(二)
|
|
WO2025090858A1
(en)
*
|
2023-10-27 |
2025-05-01 |
Biogen Ma Inc. |
Methods for identifying aav capsid variants with desired characteristics
|
|
TW202545971A
(zh)
|
2024-02-08 |
2025-12-01 |
美商戴諾治療公司 |
殼體多肽及其使用方法
|
|
US20250276095A1
(en)
|
2024-03-04 |
2025-09-04 |
Kate Therapeutics, Inc. |
Adeno-associated virus compositions for the treatment of duchenne muscular dystrophy
|
|
CN118667855A
(zh)
*
|
2024-05-31 |
2024-09-20 |
扬州大学 |
一种具有肌肉靶向性促进骨形成的噬菌体的构建方法及其应用
|
|
WO2025250909A1
(en)
|
2024-05-31 |
2025-12-04 |
Sarepta Therapeutics, Inc. |
Muscle-tropic recombinant aav
|
|
WO2026006341A1
(en)
|
2024-06-24 |
2026-01-02 |
Regenxbio Inc. |
Microdystrophin gene therapy administration for treatment of dystrophinopathies
|
|
WO2026011009A1
(en)
|
2024-07-02 |
2026-01-08 |
Kate Therapeutics, Inc. |
Compositions and methods for muscle disorders
|
|
WO2026030242A1
(en)
|
2024-07-29 |
2026-02-05 |
Kate Therapeutics, Inc. |
Adeno-associated virus compositions for the treatment of facioscapulohumeral muscular dystrophy
|
|
WO2026030244A1
(en)
|
2024-07-30 |
2026-02-05 |
Kate Therapeutics, Inc. |
Adeno-associated virus compositions for the treatment of limb girdle muscular dystrophy 2a
|
|
WO2026041758A1
(en)
|
2024-08-22 |
2026-02-26 |
Genethon |
Modified aav capsid with enhanced transduction efficiency
|
|
WO2026050402A1
(en)
|
2024-08-29 |
2026-03-05 |
Kate Therapeutics, Inc. |
Liver de-targeted muscle tropic capsids
|
|
WO2026064442A2
(en)
|
2024-09-18 |
2026-03-26 |
Dyno Therapeutics, Inc. |
Capsid polypeptides and methods of use thereof
|
|
WO2026064739A1
(en)
*
|
2024-09-23 |
2026-03-26 |
Carbon Biosciences, Inc. |
Parvovirus compositions and related methods for gene therapy
|
|
WO2026069251A1
(en)
*
|
2024-09-30 |
2026-04-02 |
Sarepta Therapeutics, Inc. |
Adeno-associated virus capsid antibodies and fragments thereof
|